Xtant Medical Holdings, Inc.
Price Action
Technical Summary
CONSOLIDATINGXtant Medical Holdings, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 24), showing significant lag compared to the market leaders. Earnings growth of 124% provides fundamental context to the price action. Investors should exercise caution due to high volatility (64% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.52 | +11.04% | ABOVE |
| 50 SMA | $0.55 | +4.53% | ABOVE |
| 100 SMA | $0.61 | -5.41% | BELOW |
| 150 SMA | $0.65 | -10.61% | BELOW |
| 200 SMA | $0.64 | -9.90% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is XTNT in an uptrend right now?
XTNT has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is XTNT overbought or oversold?
XTNT's RSI (14) is 62. The stock is in neutral territory, neither overbought nor oversold.
Is XTNT outperforming the market?
XTNT has a Relative Strength (RS) Rating of 24 out of 99. XTNT is currently lagging the broader market.
Where is XTNT in its 52-week range?
XTNT is trading at $0.58, which is 61% of its 52-week high ($0.95) and 27% above its 52-week low ($0.44).
How volatile is XTNT?
XTNT has a Beta of 0.69 and 52-week volatility of 64%. It's less volatile than the S&P 500 - generally more stable.